We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecule Found that Modulates G Protein Degradation

By Biotechdaily staff writers
Posted on 06 Aug 2003
Researchers have found that GAIP interacting protein N terminus (GIPN), a component of the ubiquitin system, plays a key role in the degradation of G proteins, a family of proteins located in the intracellular portion of the plasma membrane. More...
These proteins bind activated receptor complexes and, through conformational changes and cyclic binding and hydrolysis of GTP, directly or indirectly effect alterations in channel gating, thereby coupling cell surface receptors to intracellular responses.

Investigators the University of California, San Diego (USA) isolated GIPN and showed that it was a 38-kDa protein with an N-terminal leucine-rich region, a central RING finger-like domain, and a putative C-terminal transmembrane domain. GIPN bound exclusively to RGS proteins of subfamily A, RGS-GAIP, RGSZ1, and RGSZ2. These findings were published in the July 8, 2003, issue of the Proceedings of the National Academy of Sciences.

"As usual with scientific projects like this one, you have to go much more into the details of the mechanism,” said senior author Dr. Marilyn Farquhar, chairperson of the department of cellular and molecular medicine at the University of California, San Diego. "We have a number of experiments now underway to firm up the precise mechanism. Discovery is finding something new, in this case, a new protein. Then, it takes a long time to work out the biology.”


New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.